KRYS · Krystal Biotech Inc.
AI read · Good for KRYS
The AI's read
This gives Krystal an early sign that KB113 may help people with Gorlin syndrome, who can face repeated skin surgeries. The result also builds on its work in rare skin conditions. Still, only 3 adults took part, and the company has not announced a settled development plan after its FDA discussions. The broad responses and mild or moderate side effects make the update encouraging, but it does not yet show how the treatment works in a larger group.